1. Home
  2. HRZN vs TOI Comparison

HRZN vs TOI Comparison

Compare HRZN & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horizon Technology Finance Corporation

HRZN

Horizon Technology Finance Corporation

HOLD

Current Price

$4.40

Market Cap

303.1M

Sector

Finance

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$5.30

Market Cap

512.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRZN
TOI
Founded
2008
2007
Country
United States
United States
Employees
N/A
641
Industry
Finance/Investors Services
Medical/Nursing Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
303.1M
512.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HRZN
TOI
Price
$4.40
$5.30
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
$6.50
$6.67
AVG Volume (30 Days)
839.7K
1.8M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
33.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.25
$30.15
Revenue Next Year
$22.53
$25.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.80
$2.02
52 Week High
$8.46
$5.58

Technical Indicators

Market Signals
Indicator
HRZN
TOI
Relative Strength Index (RSI) 50.76 67.02
Support Level $3.93 $2.91
Resistance Level $4.74 N/A
Average True Range (ATR) 0.19 0.39
MACD 0.01 0.03
Stochastic Oscillator 55.00 78.97

Price Performance

Historical Comparison
HRZN
TOI

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: